Citation Tools

Download PDFPDF
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY

Download to a citation manager

Cite this article as:
Wasemann C, Ertan AK, Schmidt W, et al
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY